Patent · US Active

Compositions and methods for gene expression

US8227193B2 · kind B2 · utility

2Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 29, 2004
Grant dateJul 24, 2012
Priority date
Expiry dateNov 11, 2027

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/02
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention provides nucleotide sequences that mediate one or more functions of IKKα, kits and methods for using these sequences to identify therapeutic compounds that alter IKKα related pathology.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.